Condition: Chronic Coronary Disease · Sponsor: Weill Medical College of Cornell University
The purpose of this study is to compare the effect of ticagrelor plus low-dose aspirin versus low-dose aspirin alone in patients with chronic coronary disease undergoing coronary artery bypass grafting.
This description comes directly from the study's public registry record.
Trisha Ali-Shaw · 646-962-8281 · tra2002@med.cornell.edu
Always discuss trial participation with your own doctor first.
| Englewood Hospital | Englewood, New Jersey, United States | Recruiting |
| NewYork-Presbyterian: Queens Hospital | Flushing, New York, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| Medical University Innsbruck | Innsbruck, Innsbruck, Austria | Recruiting |
| Medical University Graz | Graz, Austria | Recruiting |
| Johannes Kepler University Linz | Linz, Austria | Recruiting |
| Medical University of Vienna | Vienna, Austria | Recruiting |
| University of Ottawa Heart Institute | Ottawa, Ontario, Canada | Not Yet Recruiting |
| Ruijin Hospital: Shanghai Jiao Tong University School of Medicine | Shanghai, China, China | Recruiting |
| Jilin Heart Hospital | Changchun, Jilian, China | Recruiting |
| Beijing Anzhen Hospital | Beijing, China | Recruiting |
| Center China Fuwai Hospital | Beijing, China | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05997693